Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANI PHARMACEUTICALS, INC.

(ANIP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ANI Pharmaceuticals : to Discuss Second Quarter 2021 Financial Results on August 6, 2021

07/22/2021 | 04:31pm EDT

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2021 financial results on Friday, August 6, 2021.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date

Friday, August 6, 2021

Time

8:30 a.m. ET

Toll free (U.S.)

866-342-8591

Webcast (live and replay)

www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for one-week by dialing 800-695-0974 and entering access code 5412658.

About ANI

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. We focus on niche and high barrier to entry opportunities including controlled substances, oncology products (anti-cancers), hormones and steroids, and complex formulations. For more information, please visit our website www.anipharmaceuticals.com.


ę Business Wire 2021
All news about ANI PHARMACEUTICALS, INC.
09/20ANI PHARMACEUTICALS : to Present at Cantor Virtual Global Healthcare Conference 2021
BU
09/17ANI PHARMACEUTICALS : Launches Generic Hypertension Drug
MT
09/17ANI PHARMACEUTICALS : Announces Launch of Nebivolol Tablets
BU
09/17ANI Pharmaceuticals, Inc. Announces Launch of Nebivolol Tablets
CI
08/31ANI PHARMACEUTICALS : Says FDA Accepts for Review Its Supplemental New Drug Application fo..
MT
08/31ANI PHARMACEUTICALS : FDA Accepts Application for Cortrophin Gel Revival
DJ
08/31ANI PHARMACEUTICALS : Announces FDA Acceptance of Purified Cortrophin« Gel Supplemental Ne..
BU
08/31Ani Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin« Gel Supplemental N..
CI
08/06ANI PHARMACEUTICALS : Posts Lower Q2 Earnings, Revenue Increases
MT
08/06ANI PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
More news
Analyst Recommendations on ANI PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 210 M - -
Net income 2021 -15,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -25,2x
Yield 2021 -
Capitalization 387 M 387 M -
Capi. / Sales 2021 1,85x
Capi. / Sales 2022 1,59x
Nbr of Employees 369
Free-Float 77,0%
Chart ANI PHARMACEUTICALS, INC.
Duration : Period :
ANI Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANI PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 31,95 $
Average target price 45,00 $
Spread / Average Target 40,8%
EPS Revisions
Managers and Directors
Nikhil Lalwani President, Chief Executive Officer & Director
Stephen P. Carey Chief Financial Officer, Secretary & VP
Patrick D. Walsh Chairman
James G. Marken Senior VP-Operations & Product Development
Robert E. Brown Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ANI PHARMACEUTICALS, INC.10.02%387
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037